Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome
Open Access
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 82 (2), 185-191
- https://doi.org/10.1016/s1081-1206(10)62595-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Biochemical Evidence for a Novel Low Molecular Weight 2-5A-Dependent RNase L in Chronic Fatigue SyndromeJournal of Interferon & Cytokine Research, 1997
- Clinical Improvement in Chronic Fatigue Syndrome Is Not Associated with Lymphocyte Subsets of Function or ActivationClinical Immunology and Immunopathology, 1997
- Immune Responses Associated with Chronic Fatigue Syndrome: A Case-Control StudyThe Journal of Infectious Diseases, 1997
- Alpha Interferon Treatment of Patients with Chronic Fatigue SyndromeImmunological Investigations, 1996
- Upregulation of the 2-5A Synthetase/RNase L Antiviral Pathway Associated with Chronic Fatigue SyndromeClinical Infectious Diseases, 1994
- Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depressionClinical and Experimental Immunology, 1992
- History of Chronic Fatigue SyndromeClinical Infectious Diseases, 1991
- Serologic and Virologic Epidemiology of Epstein-Barr Virus: Relevance to Chronic Fatigue SyndromeClinical Infectious Diseases, 1991
- Acyclovir Treatment of the Chronic Fatigue SyndromeNew England Journal of Medicine, 1988
- Allergy and the chronic fatigue syndromeJournal of Allergy and Clinical Immunology, 1988